Prevalence and antimicrobial resistance of highly virulent cagA-positive Helicobacter pylori strains in Southern Poland
- PMID: 39688753
- DOI: 10.1007/s10096-024-05018-z
Prevalence and antimicrobial resistance of highly virulent cagA-positive Helicobacter pylori strains in Southern Poland
Abstract
Purpose: Assessment of Helicobacter pylori (H. pylori) prevalence in Southern Poland, focusing on highly virulent cagA-positive strains associated with gastric cancer risk, along with analysis of antimicrobial resistance and its molecular mechanisms.
Methods: A total of 130 dyspeptic patients, who underwent endoscopy, were enrolled in the study. Presence of H. pylori in gastric mucosa biopsy specimens was confirmed by rapid urease tests, histological examination, culture, and molecular assays. Antimicrobial susceptibility was tested using the E-test, while the cagA gene (virulence marker) was identified by PCR. The GenoType HelicoDR detected mutations for resistance to clarithromycin (23 S rRNA) and levofloxacin (gyrA). Resistance to rifampicin and levofloxacin was investigated by sequencing the rpoB and gyrA genes.
Results: H. pylori prevalence in Southern Poland was 30.8%, with 60% of infections involving cagA-positive strains. Susceptibility testing revealed resistance rates of 22.9% for metronidazole, 14.3% for clarithromycin, 11.4% for levofloxacin and 25.7% for rifampicin. Among the 24 cagA-positive strains, 45.8% were resistant to at least one antibiotic. Clarithromycin resistance was caused by A2143G mutation. The gyrA gene sequence showed the N87K mutation linked to fluoroquinolone resistance. No mutations were found in the rpoB gene.
Conclusion: Infections with multidrug-resistant CagA-positive strains require recommended treatment strategies due to the high risk of progression of infection to gastric cancer.
Keywords: Helicobacter pylori; Antimicrobial resistance; CagA protein; Gastric cancer; Peptic ulcer disease; Sequencing; Treatment; Virulence factors.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Bioethical Commission of the Jagiellonian University (Krakow, Poland; No. 122.6120.273.2015). Before participating in the study, each patient signed an informed consent form for participation in the research project. Competing interests: The authors declare no competing interests.
Similar articles
-
Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis.Infect Genet Evol. 2016 Oct;44:190-198. doi: 10.1016/j.meegid.2016.06.044. Epub 2016 Jun 26. Infect Genet Evol. 2016. PMID: 27355861
-
Can bacterial virulence factors predict antibiotic resistant Helicobacter pylori infection?World J Gastroenterol. 2018 Mar 7;24(9):971-981. doi: 10.3748/wjg.v24.i9.971. World J Gastroenterol. 2018. PMID: 29531461 Free PMC article.
-
Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance.Microb Pathog. 2018 Oct;123:330-338. doi: 10.1016/j.micpath.2018.07.016. Epub 2018 Jul 18. Microb Pathog. 2018. PMID: 30031039
-
Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis.BMC Infect Dis. 2022 Jun 25;22(1):573. doi: 10.1186/s12879-022-07546-5. BMC Infect Dis. 2022. PMID: 35752757 Free PMC article.
-
Natural small-molecule compounds targeting Helicobacter pylori virulence factors: A promising strategy for overcoming antibiotic resistance.Biochem Biophys Res Commun. 2025 Jul 1;768:151877. doi: 10.1016/j.bbrc.2025.151877. Epub 2025 Apr 23. Biochem Biophys Res Commun. 2025. PMID: 40334425 Review.
References
-
- Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC (2017) Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis Gastroenterology. 153(2):420–429. https://doi.org/10.1053/j.gastro.2017.04.022
-
- Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E (2018) Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health. Organ Reg Gastroenterol 155(5):1372–1382e17. https://doi.org/10.1053/j.gastro.2018.07.007 - DOI
-
- Perez-Perez GI, Rothenbacher D, Brenner H (2004) Epidemiology of Helicobacter pylori infection Helicobacter 9 Suppl 1:1–6. https://doi.org/10.1111/j.1083-4389.2004.00248.x
-
- Karczewska E, Klesiewicz K, Skiba I, Wojtas-Bonior I, Sito E, Czajecki K, Zwolińska-Wcisło M, Budak A (2012) Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland. Gastroenterol Res Pract 2012:418010. https://doi.org/10.1155/2012/418010 - DOI - PubMed - PMC
-
- Korona-Glowniak I, Cichoz-Lach H, Siwiec R, Andrzejczuk S, Glowniak A, Matras P, Malm A (2019) Antibiotic Resistance and Genotypes of Helicobacter pylori Strains in Patients with Gastroduodenal Disease in Southeast Poland. J Clin Med 21(7):1071. https://doi.org/10.3390/jcm8071071 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical